
Neurologist

No OPD information available
Thrombectomy
Aortic Dissection
Stroke
Subarachnoid Hemorrhage
Andrew K. Cheung is a male medical professional who specializes in providing treatments for conditions like Thrombectomy, Aortic Dissection, Stroke, and Subarachnoid Hemorrhage. He helps patients by using special skills and treatments to improve their health.
Andrew K. Cheung communicates with patients in a caring and clear way, which helps patients trust him. Patients feel comfortable discussing their health concerns with him because he listens carefully and explains things in a simple manner.
To stay updated with the latest medical knowledge and research, Andrew K. Cheung regularly attends conferences, reads medical journals, and collaborates with other experts in the field. This helps him provide the best possible care to his patients.
Andrew K. Cheung works well with colleagues and other medical professionals by sharing his knowledge and expertise. He values teamwork and believes that working together leads to better outcomes for patients.
Through his work, Andrew K. Cheung has positively impacted many patients' lives by providing effective treatments and compassionate care. His dedication to improving patient outcomes has earned him the trust and respect of his patients and colleagues.
One of Andrew K. Cheung's notable publications is "Recurrent CT perfusion imaging abnormalities in a patient with bow hunter's syndrome," published in BMJ case reports on February 26, 2025. He has also conducted a clinical trial called "STOP-MSU," which aimed to improve outcomes for patients with intracerebral hemorrhage.
In summary, Andrew K. Cheung is a skilled and compassionate medical professional who is dedicated to providing the best possible care for his patients. Through his expertise, communication skills, and commitment to ongoing learning, he continues to make a positive impact on the lives of those he treats.
Enrollment Status: Completed
Published: September 28, 2023
Intervention Type: Drug
Study Drug: Tranexamic Acid
Study Phase: Phase 2
